Retrospective Analyses of TrakStar Database

Last updated: March 31, 2025
Sponsor: Neuronetics
Overall Status: Active - Recruiting

Phase

N/A

Condition

Anxiety Disorders

Obsessive-compulsive Disorder

Kleptomania

Treatment

NeuroStar Advanced TMS Therapy System

Clinical Study ID

NCT06917339
11-10000-000
  • Ages 5-120
  • All Genders

Study Summary

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male or female reported in database and not an invalid entry

  • Age reported and not an invalid entry

  • Treatment date of November 01, 2008 or later.

Exclusion

Exclusion Criteria:

• Incomplete information on treatment parameters

Study Design

Total Participants: 156000
Treatment Group(s): 1
Primary Treatment: NeuroStar Advanced TMS Therapy System
Phase:
Study Start date:
February 25, 2025
Estimated Completion Date:
December 31, 2035

Connect with a study center

  • Neuronetics

    Malvern, Pennsylvania 19355
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.